# Total Body Irradiation +/- Total Lymphoid Irradiation & Anti-Thymocyte Globulin in Non-myeloablative Hematopoietic Cell Transplantation

> **NCT03734601** · PHASE2 · COMPLETED · sponsor: **Stanford University** · enrollment: 22 (actual)

## Conditions studied

- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- Myeloproliferative Disorder
- Chronic Lymphocytic Leukemia
- B-cell Lymphoma
- T-cell Lymphoma
- Non Hodgkin Lymphoma
- Hodgkin Lymphoma
- Chronic Myelomonocytic Leukemia

## Interventions

- **RADIATION:** Total body irradiation (TBI)
- **DRUG:** Anti-thymocyte globulin (ATG)
- **DRUG:** Tacrolimus
- **DRUG:** Mycophenolate mofetil (MMF)
- **RADIATION:** Total lymphoid irradiation (TLI)

## Key facts

- **NCT ID:** NCT03734601
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-05
- **Primary completion:** 2019-12-26
- **Final completion:** 2020-11-17
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2023-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03734601

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03734601, "Total Body Irradiation +/- Total Lymphoid Irradiation & Anti-Thymocyte Globulin in Non-myeloablative Hematopoietic Cell Transplantation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03734601. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*